Skip to main content
All lobbying filings

STUDENTS FOR SENSIBLE DRUG POLICY

STUDENTS FOR SENSIBLE DRUG POLICY filed a Q3 report for STUDENTS FOR SENSIBLE DRUG POLICY on October 15, 2025.

Lobbying for STUDENTS FOR SENSIBLE DRUG POLICY

All filings by STUDENTS FOR SENSIBLE DRUG POLICY · Everything STUDENTS FOR SENSIBLE DRUG POLICY has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 15, 2025
Expenses
$10,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Civil Rights/Civil Liberties

STATES 2.0 Act (HR 2934): Issues related state cannabis laws and provisions to enable interstate commerce. PREPARE Act (HR 2935): Issues related to the establishment of a federal commission to design a pathway for full federal cannabis regulation. Evidence-Based Drug Policy Act (HR 3082): Issues related to the authorization of federal agencies to study cannabis legalization and stops requiring the Drug Czar to oppose reform efforts. MORE Act (HR 5068): Issues related to the removal of cannabis from the Controlled Substances Act, expunging certain past convictions, and reinvesting in communities disproportionately harmed by prohibition.

Veterans

Veterans Cannabis Use for Safe Healing Act (HR 966): Issues related to the denial of VA benefits to veterans enrolled in state-approved medical cannabis programs and requiring VA providers to discuss and document cannabis use and adjust treatment. Veterans Equal Access Act (HR 1384): Issues related to the authorization of the VA to offer veterans recommendations and opinions regarding participation in their state's respective cannabis programs. Innovative Therapies Centers of Excellence Act of 2025 (HR 2623): Issues related to the designation of at least five VA medical facilities as Innovative Therapies Centers of Excellence.

 Bills named in this filing 7

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem